Furthermore, in breast cancer, elevated HJURP levels emerged as an independent prognostic marker of poor patient outcome, distinguishing aggressive tumors within the luminal A subtype (Montes de Oca et al. 2015). This evidence concerns the gene HJURP and breast carcinoma.